Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 1;28(1):e1-e5.
doi: 10.1097/SPV.0000000000001108.

Evidence for Early Cyclosporine Treatment for Hunner Lesion Interstitial Cystitis

Annah Vollstedt  1 , Lauren Tennyson  1 , Katherine Turner  1 , Deborah Hasenau  1 , Md Saon  2 , Teresa McCartney  1 , Dana Beck  1 , Jason Gilleran  1 , Kenneth Peters  1
Affiliations

Evidence for Early Cyclosporine Treatment for Hunner Lesion Interstitial Cystitis

Annah Vollstedt et al. Female Pelvic Med Reconstr Surg. .

Abstract

Objectives: The objective of this study was to evaluate our experience using cyclosporine A (CyA) in the treatment of Hunner lesion interstitial cystitis (HLIC).

Methods: Retrospective chart review was performed on patients with HLIC treated with CyA from August 2012 to September 2019. Demographic and clinical variables, number of interstitial cystitis therapies, frequency, nocturia, and bladder pain visual analog scores before and after CyA treatment were collected, as well as the Global Response Assessment (GRA) and the Interstitial Cystitis Symptom Index and Interstitial Cystitis Problem Index. CyA responders were defined as those with moderately or markedly improved GRA scores.

Results: A total of 51 patients with HLIC treated with CyA were identified. Mean follow-up was 3 years (0.36-6.8 years). Seventy-six percent (28 of 37) were female; mean age was 68 years (51-84 years). Before CyA treatment, an average of 8 previous therapies were tried and patients reported an average of 8 of 10 bladder pain. Daytime frequency was 11-20 times per day, and nocturia was 7 times per night. Per the GRA, 84% (31 of 37) were considered CyA responders. Posttherapy Interstitial Cystitis Symptom Index and Interstitial Cystitis Problem Index scores were lower in responders compared with nonresponders (8.9 ± 5.7 vs 21.3 ± 7.0, P = 0.001). Bladder pain, number of hydrodistentions/fulgurations, nocturia, and daytime frequency improved significantly after CyA treatment.

Conclusions: The cyclosporine A response rate was 84%, with most of these patients reporting marked improvement. Bladder pain, daytime frequency, and nocturia were significantly improved after CyA treatment, and the number of interventions after CyA treatment decreased. Cyclosporine A should be considered earlier than fifth-line therapy in HLIC.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Comment in

References

    1. Hanno P, Dmochowski R. Status of international consensus on interstitial cystitis/bladder pain syndrome/painful bladder syndrome: 2008 snapshot. Neurourol Urodyn 2009;28(4):274–286. doi: 10.1002/nau.20687. - DOI
    1. Kim A, Han JY, Ryu CM, et al. Histopathological characteristics of interstitial cystitis/bladder pain syndrome without Hunner lesion. Histopathology 2017;71(3):415–424. doi: 10.1111/his.13235. - DOI
    1. Whitmore KE, Fall M, Sengiku A, et al. Hunner lesion versus non–Hunner lesion interstitial cystitis/bladder pain syndrome. Int J Urol 2019;26(Suppl 1):26–34. doi: 10.1111/iju.13971. - DOI
    1. Peters KM, Carrico DJ. Frequency, urgency, and pelvic pain: treating the pelvic floor versus the epithelium. Curr Urol Rep 2006;7(6):450–455. doi: 10.1007/s11934-006-0053-6. - DOI
    1. Bassaly R, Tidwell N, Bertolino S, et al. Myofascial pain and pelvic floor dysfunction in patients with interstitial cystitis. Int Urogynecol J 2011;22(4):413–418. doi: 10.1007/s00192-010-1301-3. - DOI

Publication types

LinkOut - more resources